BCPC

Balchem Corporation

BCPC.US balchem.com
168.46
-2.10 (-1.23%)
USD · NASDAQ
52-week range
138.32
183.90
Trading at 66% of the 52-week range
Market Cap
5.44B
P/E Ratio
33.57
Forward P/E
29.85
Book Value
40.76
Div. Yield
0.56%
% Institutions
93.86%
% Insiders
0.472%

1 Year

+5.8%

3 Year

+31.1%

10 Year

+165.6%
Description

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Company Information

Company Name
Balchem Corporation
Sector
Basic Materials
Industry
Specialty Chemicals
Exchange
NASDAQ
ISIN: US0576652004
CIK: 0000009326
CUSIP: 057665200
Currency: USD
Full Time Employees: 1,379
Phone: 845 326 5600
Website: balchem.com
Fiscal Year End: December
IPO Date: Jun 03, 1986
Description:

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Address:

5 Paragon Drive, Montvale, NJ, United States, 07645

People

Directors & Officers

Name Title Year Born
Mr. Theodore Lee Harris CEO, President & Chairman 1965
Mr. Carl Martin Bengtsson Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health 1977
Ms. Hatsuki Miyata J.D. Executive VP, Chief Legal Officer & Secretary 1976
Mr. M. Brent Tignor Senior VP & Chief Human Resources Officer 1978
Mr. Frederic Boned Senior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health 1979
Ms. Erin L. Gilson VP & Chief Accounting Officer NA
Mr. Martin Luther Reid Senior VP & Chief Supply Chain Officer 1967
Mr. Job L. van Gunsteren Senior VP & GM of Specialty Products 1977
Mr. George Graham Senior VP and Chief R&D Officer 1970

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 04, 2025 Gunsteren Job Leonard Van N/A Sale 6.00K $153.29 $919.74K
Dec 03, 2025 David B Fischer N/A Sale 8.00K $153.97 $1.23M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 4.84M Mar 31, 2026 15.19% $0.01 -1.41%
Vanguard Portfolio Management, LLC 2.19M Mar 31, 2026 6.88% $0.02 0.00%
Vanguard Capital Management, LLC 1.43M Mar 31, 2026 4.49% $0.01 0.00%
State Street Corp 1.24M Mar 31, 2026 3.89% $0.01 2.53%
Conestoga Capital Advisors, LLC 1.09M Jun 30, 2026 3.41% $4.00 -13.05%
Wasatch Advisors LP 1.05M Jun 30, 2026 3.30% $1.16 -26.18%
Geode Capital Management, LLC 1.05M Mar 31, 2026 3.29% $0.01 4.11%
Morgan Stanley - Brokerage Accounts 857.37K Mar 31, 2026 2.69% $0.01 -7.43%
Geneva Capital Management 683.10K Jun 30, 2026 2.14% $2.65 -19.30%
First Trust Advisors L.P. 617.23K Jun 30, 2026 1.94% $0.06 36.15%
Dimensional Fund Advisors, Inc. 610.05K Jun 30, 2026 1.91% $0.02 2.23%
FMR Inc 598.67K Mar 31, 2026 1.88% $0.01 11.82%
Congress Asset Management Company, LLP 502.57K Jun 30, 2026 1.58% $0.52 12.73%
Schroder Investment Management Group 440.42K Jun 30, 2026 1.38% $0.05 22.17%
Two Sigma Investments LLC 430.21K Mar 31, 2026 1.35% $0.06 112.23%
JPMorgan Chase & Co 427.00K Mar 31, 2026 1.34% $0.00 -16.44%
NORGES BANK 411.88K Jun 30, 2026 1.29% $0.01 -1.57%
Nuveen, LLC 393.49K Mar 31, 2026 1.23% $0.02 -0.69%
Northern Trust Corp 373.98K Mar 31, 2026 1.17% $0.01 2.39%
Charles Schwab Investment Management Inc 369.46K Mar 31, 2026 1.16% $0.01 1.19%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 1.96M 6.14% ▲ 0.03% Aug 31, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 1.02M 3.21% ▲ 0.30% Jul 31, 2026
3 iShares Russell 2000 ETF 833.63K 2.62% ▼ 0.57% Aug 31, 2026
4 Vanguard Small Cap Index 738.84K 2.32% ▲ 0.28% Jul 31, 2026
5 First Trust SMID Cp Rising Div Achv ETF 574.57K 1.80% ▲ 0.06% Aug 31, 2026
6 Conestoga Small Cap Investors 449.42K 1.41% ▼ 11.70% Jul 31, 2026
7 Vanguard MStar Small Cap Growth Indx Inv 426.54K 1.34% ▲ 0.27% Jul 31, 2026
8 Wasatch Core Growth 411.13K 1.29% ▼ 26.90% Jun 30, 2026
9 Vanguard Institutional Extnd Mkt Idx Tr 370.16K 1.16% ▲ 0.33% Jul 31, 2026
10 Fidelity Small Cap Index 355.04K 1.11% ▲ 8.85% Jun 30, 2026

Financial Highlights

Market Cap: $5.44B
EBITDA: $269.41M
P/E Ratio: $33.57
PEG Ratio: $3.32
Book Value: $40.76
Dividend/Share: $0.96
Dividend Yield: 0.56%
Earnings/Share: $5.08
Profit Margin: 15.14%
Operating Margin: 20.85%
ROA (TTM): 8.23%
ROE (TTM): 12.79%
Revenue (TTM): $1.09B
Revenue/Share (TTM): $33.91
Earnings Growth (YOY): 18.80%
Revenue Growth (YOY): 11.20%

Valuation Metrics

Enterprise Value: $5.57B
Trailing P/E: 33.57
Forward P/E: 29.85

Shares Statistics

Shares Outstanding: 31.88M
Shares Float: 31.69M
% Insiders: 0.472%
% Institutions: 93.86%
Short % Float: 2.61%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.04B
Cost of Goods Sold
adjust
$-666.53M
Gross Profit
subtotal
$370.63M
SG&A
adjust
$-67.42M
R&D
adjust
$-18.51M
Other Operating Expense
adjust
$-66.37M
Operating Income
subtotal
$218.33M
Other / Non-Operating Items
adjust
$-63.49M
Net Income
subtotal
$154.85M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BCPC.US!